The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
IPO Year: 2015
Exchange: NYSE
Website: chemours.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/28/2025 | $27.00 | Buy | Truist |
| 7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
| 6/7/2024 | $25.00 | Neutral | Mizuho |
| 4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
| 3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
| 2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
| 12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 6/22/2023 | $41.00 → $37.00 | Buy → Neutral | BofA Securities |
| 1/24/2023 | $31.00 → $43.00 | Neutral → Buy | UBS |
| 1/11/2023 | $37.00 → $40.00 | Neutral → Buy | BofA Securities |
8-K - Chemours Co (0001627223) (Filer)
10-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)
SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K/A - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours' Board of Directors The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211667601/en/Chemours appoints Leslie M. Turner to its Board
The Chemours Company (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours' Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
Board addition brings strong tech industry expertise to advance the company's Pathway to Thrive business strategy The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to its Board of Directors, effective January 3, 2025. Joe brings three decades of experience gained in leadership, operational, and technical roles at some of the world's leading technology companies. He currently serves as Vice President of Data Centers at Google (NASDAQ:GOOG), where he has overseen site selection, design, construction management, operations, power purchasing, engineering, facility and hardware appli
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston "Tony" Satterthwaite to its Board of Directors, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613653963/en/Tony Satterthwaite named to Chemours' Board of Directors (Photo: Business Wire) "I'm pleased to welcome Tony as the newest member of Chemours' Board of Directors," said Dawn Farrell, Chair of the Board of Chemours. "Tony brings extensive leadership and board expe
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605314740/en/Shane Hostetter, Chief Financial Officer (Photo: Business Wire) "Shane is a welcome addition to the Chemours team. With over 20 years' experience in a
LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' opt
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' opt
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' o
3 - Chemours Co (0001627223) (Issuer)
3 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
3 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announces the launch of Ti-Pure™ TS-6706, a TMP- and TME- free version of Ti-Pure™ R-706 – the benchmark, universal titanium dioxide (TiO2) grade that works reliably for a variety of coatings applications where appearance is critical. "As the industry's trusted TiO2 partner, we are thrilled to offer a TMP- and TME-free version of our most popular pigment," said Diane Picho, Interim President, Chemours Titanium Technologies. "The development of Ti-Pure™ TS-6706 is the latest e
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut
GREENWICH, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- QXO, Inc. (NYSE:QXO) announced today that it has informed Beacon Roofing Supply, Inc. (NASDAQ:BECN) that it will propose 10 independent director nominees at Beacon's 2025 Annual Meeting of Shareholders to replace Beacon's Board of Directors. The slate of independent nominees includes current and former senior executives and directors of leading global companies who were selected for their deep expertise with large-scale corporate transformations, extensive knowledge of the building products and distribution sectors, and track records of unlocking shareholder value. "We are proposing a slate of high-caliber, independent director nominees
Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours' Board of Directors The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211667601/en/Chemours appoints Leslie M. Turner to its Board
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (
The Chemours Company (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours' Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
Board addition brings strong tech industry expertise to advance the company's Pathway to Thrive business strategy The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to its Board of Directors, effective January 3, 2025. Joe brings three decades of experience gained in leadership, operational, and technical roles at some of the world's leading technology companies. He currently serves as Vice President of Data Centers at Google (NASDAQ:GOOG), where he has overseen site selection, design, construction management, operations, power purchasing, engineering, facility and hardware appli
The Chemours Company (Chemours) (NYSE:CC) today announced the successful repricing of its Tranche B-3 Euro denominated Term Loan under its senior secured term loan facility due in August 2028. The Second Amendment reduces the applicable margin in respect of the Company's €415,000,000 Euro denominated term loan facility, the "Tranche B-3 Euro Term Loan Facility," from adjusted EURIBOR + 4.00% to adjusted EURIBOR + 3.25%. There are no changes to the maturity of the Term B-3 Euro Term Loan Facility following this repricing, and all other terms are substantially unchanged. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty ch
The Chemours Company (Chemours) (NYSE:CC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant be
The Chemours Company (Chemours) (NYSE:CC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028. The repricing reduces the applicable margin in respect of the Company's $1,070,000,000 senior secured U.S. dollar-denominated term loan facility, the "Term Loan B-3 US$ Facility," from, at the election of the Company, adjusted Term SOFR + 3.50% to adjusted Term SOFR + 3.00%, or adjusted base rate plus 2.50% to adjusted base rate plus 2.00%. There are no changes to the maturity of the Term Loan B-3 US$ Facility following this repricing, and all other terms are substantially unchanged. About
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
Mizuho initiated coverage of Chemours with a rating of Neutral and set a new price target of $25.00
BMO Capital Markets upgraded Chemours from Underperform to Outperform and set a new price target of $34.00 from $19.00 previously
UBS downgraded Chemours from Buy to Neutral and set a new price target of $21.00 from $37.00 previously
BMO Capital Markets downgraded Chemours from Outperform to Underperform and set a new price target of $19.00 from $45.00 previously
RBC Capital Mkts upgraded Chemours from Sector Perform to Outperform and set a new price target of $40.00 from $28.00 previously
BofA Securities downgraded Chemours from Buy to Neutral and set a new price target of $37.00 from $41.00 previously
UBS upgraded Chemours from Neutral to Buy and set a new price target of $43.00 from $31.00 previously
BofA Securities upgraded Chemours from Neutral to Buy and set a new price target of $40.00 from $37.00 previously
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solu
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024. The Company expects to hold its conference call to discuss its third quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Monday, November 4, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC)
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company expects to hold its conference call to discuss its second quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Friday, August 2, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (N
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record as of the close of business on May 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solut
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2024 financial results after market close on Tuesday, April 30, 2024. The Company expects to hold its conference call to discuss its first quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 1, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYS
The company was recognized for its achievements in energy efficiency and waste reduction at the DOE Better Buildings, Better Plants Summit The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, was honored yesterday with two awards from the U.S. Department of Energy's (DOE) Better Buildings, Better Plants initiative, which recognizes partners for outstanding accomplishments in energy efficiency, decarbonization, water efficiency, or waste reduction projects or practices. This is the second year that Chemours has been recognized with both Better Proj
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ended December 31, 2023 after market close on Wednesday, March 27, 2024. The Company expects to hold its conference call to discuss its fourth quarter and full year 2023 financial results at 8:00 a.m. Eastern Daylight Time on Thursday, March 28, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Repl